OptiNose (OPTN) Stock Chart & Stock Price History $9.60 0.00 (0.00%) As of 05/21/2025 Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock OptiNose Stock Price Performance The OptiNose (OPTN) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 43.36%, with a year-to-date return of 43.71%. In the past month, the stock has increased 4.58%, reflecting recent market activity. As of the latest close, OptiNose traded at $9.60 with a market cap of $97.22 million and volume of 0 shares. Five years ago, the stock traded at a split-adjusted price of $65.25, representing a 85.29% decrease over that period. At the time, it had a market cap of $199.94 million and a volume of 10,707 shares. Receive OPTN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for OptiNose and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-0.93%1 Month Performance+4.58%3 Month Performance+66.38%Year-To-Date Performance+43.71%1 Year Performance-43.36%5 Year Performance-85.29% OPTN Stock Chart for Friday, May, 23, 2025 OPTN Chart by TradingView OptiNose Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/21/2025$9.60$9.67+0.77%$9.72$9.48860,900 shs$97.97 million05/20/2025$9.71$9.60-1.13%$9.72$9.48841,161 shs$97.22 million05/19/2025$9.69$9.71+0.21%$9.75$9.5056,786 shs$98.33 million05/16/2025$9.52$9.69+1.79%$9.74$9.44169,941 shs$98.13 million05/15/2025$9.42$9.52+1.06%$9.58$9.4226,958 shs$96.41 million05/14/2025$9.45$9.42-0.32%$9.49$9.4215,910 shs$95.40 million05/13/2025$9.42$9.45+0.32%$9.47$9.417,508 shs$95.70 million05/12/2025$9.39$9.42+0.32%$9.43$9.408,668 shs$95.40 million05/09/2025$9.39$9.39$9.41$9.388,064 shs$95.09 million05/08/2025$9.40$9.39-0.11%$9.43$9.3721,241 shs$95.09 million Get the Latest News and Ratings for OPTN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for OptiNose and its competitors with MarketBeat's FREE daily newsletter. 05/07/2025$9.38$9.40+0.21%$9.43$9.387,277 shs$95.19 million05/06/2025$9.42$9.38-0.42%$9.44$9.3822,804 shs$94.99 million05/05/2025$9.40$9.42+0.21%$9.44$9.3820,508 shs$95.40 million05/02/2025$9.39$9.40+0.11%$9.45$9.3821,187 shs$95.19 million05/01/2025$9.32$9.39+0.75%$9.39$9.3312,393 shs$95.09 million04/30/2025$9.32$9.32$9.37$9.2817,736 shs$94.38 million04/29/2025$9.34$9.32-0.21%$9.35$9.2832,180 shs$94.38 million04/28/2025$9.28$9.34+0.65%$9.35$9.2525,408 shs$94.59 million04/25/2025$9.26$9.28+0.22%$9.30$9.2018,755 shs$93.98 million04/24/2025$9.18$9.26+0.87%$9.29$9.1847,185 shs$93.78 million04/23/2025$9.17$9.18+0.11%$9.30$9.1822,306 shs$92.97 million04/22/2025$9.16$9.17+0.11%$9.22$9.1448,206 shs$92.36 million Related Companies Organogenesis Stock Price Chart Alpha Teknova Stock Price Chart MBX Biosciences Stock Price Chart Oruka Therapeutics Stock Price Chart COMPASS Pathways Stock Price Chart Autolus Therapeutics Stock Price Chart Cryoport Stock Price Chart Checkpoint Therapeutics Stock Price Chart SNDL Stock Price Chart Entrada Therapeutics Stock Price Chart Receive OPTN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for OptiNose and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:OPTN) was last updated on 5/23/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OptiNose, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share OptiNose With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
